Peptide Storage and Reconstitution: Keeping the Science in the Vial
If there is one thing Professor PepBuddies would rather not see sacrificed in the name of convenience, it is perfectly good peptide.
Peptides can be remarkably stable under the right conditions and surprisingly temperamental under the wrong ones. Heat, moisture, light, oxidation, contamination, repeated freeze-thaw cycles, and simply using the wrong diluent can all turn a nicely prepared vial into a considerably less useful science experiment.
So let's talk about storage, reconstitution, water, syringes, pens, and one very important rule:
Always follow the storage and reconstitution instructions for the specific peptide or formulation you have.
There are useful general rules, but there are exceptions.
STORING UNRECONSTITUTED PEPTIDES
Most lyophilized synthetic research peptides can be stored frozen for longer-term storage, commonly at about -20°C. General laboratory guidance from MilliporeSigma recommends -20°C or colder for lyophilized peptides stored long term.
However, do not assume that every lyophilized peptide belongs in the freezer. Some formulations specifically require room-temperature or refrigerated storage and may explicitly say "Do not freeze."
Examples commonly stored frozen while still lyophilized include:
- BPC-157 -- dry material is commonly stored below about -18°C for longer-term stability. FDA's review of BPC-157 specifically cites this recommendation.
- Ipamorelin -- despite being a growth-hormone secretagogue, lyophilized ipamorelin is commonly stored below -18°C or around -20°C.
- CJC-1295 / Modified GRF 1-29 -- lyophilized material is commonly stored at about -20°C for long-term storage.
Ipamorelin is particularly interesting as the prevailing expertise on the internet is that freezing any peptide related to "growth hormone" or GH-fragments destroys it, and that isn't the whole story. Recombinant human growth hormone itself, however, should never be frozen.
Products containing somatropin, such as Genotropin and Humatrope, are stored refrigerated and specifically labelled "Do not freeze." That applies both before and after reconstitution according to their respective product instructions.
Tesamorelin is another useful exception. The current Egrifta WR formulation specifically says "Do not freeze" and is actually stored at controlled room temperature rather than in a freezer.
So a good practical rule is:
- Ordinary lyophilized synthetic research peptides -- often freezer storage around -20°C.
- Recombinant growth hormone products such as somatropin -- refrigerate and do not freeze.
- Commercially formulated peptides such as tesamorelin -- follow the formulation-specific instructions, which may explicitly prohibit freezing.
If you remove a vial from the freezer, let the sealed vial warm toward room temperature before opening it. This helps prevent condensation from forming inside the vial.
AFTER RECONSTITUTION
Once water is added, most peptide solutions become less stable than the dry powder. For many commonly used peptide preparations, refrigerated storage at approximately 2°C to 8°C is appropriate after reconstitution. Avoid repeatedly freezing and thawing the same working vial.
Some laboratory protocols deliberately freeze reconstituted peptide in small aliquots for long-term storage, but that is different from repeatedly moving a multi-use vial between the refrigerator and freezer.
For a vial you plan to access repeatedly, refrigeration is usually the practical choice unless the product instructions say otherwise.
BACTERIOSTATIC WATER VS. STERILE WATER
These are two examples of a diluent. There are others, too, such as Sterile Saline, but we don't work with that, generally.
First, let's get it out of the way that these are not interchangeable.
Sterile Water for Injection contains no antimicrobial preservative.
- It is normally intended for single-use preparation. Once opened, there is no preservative to inhibit microbial growth in the remaining water.
Bacteriostatic Water for Injection contains a preservative, usually 0.9% benzyl alcohol.
- That makes it suitable for multi-dose use and repeated withdrawals, provided sterile technique is maintained.
In practical terms:
- Use bacteriostatic water when the preparation will be accessed repeatedly and the peptide is compatible with it.
- Use sterile water when the product or protocol specifically calls for sterile water, particularly when the preparation is intended for immediate or single use.
Do not automatically substitute bacteriostatic water for another specified diluent. Some peptides require sterile water, saline, buffered solutions, or a supplied proprietary diluent.
HOW TO RECONSTITUTE A PEPTIDE
- Start with clean hands and a clean work surface.
- Clean the rubber stopper on both the peptide vial and diluent vial with an alcohol prep pad.
- Using a new sterile syringe and needle, withdraw the required amount of diluent.
- Introduce the diluent gently into the peptide vial.
- Avoid violently shaking the vial.
- Let the liquid dissolve the lyophilized material naturally. Gentle swirling or rolling may be appropriate if needed.
- Once dissolved, inspect the solution.
If a solution that should normally be clear appears unexpectedly cloudy, discoloured, or contains particles, do not simply assume it is fine.
Store the reconstituted vial according to the appropriate instructions, which commonly means refrigeration.
THE MATH OF RECONSTITUTION
Reconstitution is really just concentration math. A vial contains a fixed amount of peptide, and the amount of diluent you add determines how concentrated the finished solution will be.
The basic formula is: Concentration = amount of peptide ÷ volume of diluent
For example, a hypothetical 10 mg vial mixed with:
- 1 mL of diluent = 1 mg/0.1mL
- 2 mL of diluent = 0.5 mg/0.1mL
- 2.5 mL of diluent = 0.4 mg/0.1mL
- 3 mL of diluent = about 0.333 mg/0.1mL
The peptide amount has not changed. You have only changed how much liquid contains it. That can be useful because the amount of diluent can make repeated measurements easier.
Suppose you want a particular amount to correspond to a convenient syringe marking or pen increment. Choosing an appropriate dilution can make the arithmetic cleaner and reduce the chance of repeatedly measuring awkward fractions.
For U-100 insulin syringes, 100 units equals 1 mL, so:
- 10 units = 0.10 mL
- 20 units = 0.20 mL
- 25 units = 0.25 mL
- 50 units = 0.50 mL
Those markings measure liquid volume, not milligrams. To know how much peptide is in that volume, you still need to know the concentration you prepared.
For example, if a solution contains 5 mg/mL:
- 0.10 mL contains 0.5 mg
- 0.20 mL contains 1 mg
- 0.25 mL contains 1.25 mg
This same principle applies to peptide pens. Many refillable pen cartridges are around 3 mL, so concentration needs to be chosen with both the desired measurement increments and the cartridge capacity in mind.
With syringes, be aware that the unit scales can be different. A U-40 1 mL syringe is divided into 40 units, while a U-100 1 mL syringe is divided into 100 units. Both syringes still hold exactly 1 mL, but each "unit" represents a different volume: 1 unit on a U-40 syringe equals 0.025 mL, while 1 unit on a U-100 syringe equals 0.01 mL. This makes U-100 syringes more finely graduated and means the unit markings cannot be treated as equivalent between the two types. It's important to ensure when purchasing syringes supplies for research that you know what unit scale you are buying. U-100 keeps things very simple and easy to understand.
DO NOT OVERFILL THE VIAL
Many of the small vials commonly used for research peptides have a nominal capacity just under 4 mL. We don't recommend testing that limit.
The lyophilized material occupies some space, and the vial also needs headspace. Depending on the vial, stopper, and vacuum inside it, you may find that adding substantially more than about 3.25-3.5 mL becomes difficult or causes the vial to resist additional liquid.
If you need a very dilute preparation, check the actual vial capacity rather than forcing more diluent into it. You may also want to consider using a different size of syringe (0.3 mL vs 1 mL) to draw a more precise amount of the preparation.
The same applies to refillable peptide-pen cartridges. A nominal 3 mL cartridge is designed around approximately that capacity, not an unlimited amount of liquid.
MORE DILUENT VS. LESS DILUENT
There is no prize for making a peptide as concentrated as physically possible.
Using less diluent has one obvious advantage:
- The same amount of peptide can be delivered in a smaller liquid volume.
But there are tradeoffs.
Highly concentrated injectable formulations can sometimes be less comfortable for research subjects. Injection-site discomfort depends on several factors, including the compound itself, pH, osmolality, buffers, preservatives, viscosity, injection volume, and formulation concentration. There is therefore no universal concentration at which a peptide suddenly becomes "too concentrated." In practical terms, if an otherwise properly prepared solution consistently stings or causes local irritation, extreme concentration may be one factor worth considering -- provided the peptide is stable and compatible at a greater dilution.
Adding more diluent can make individual measurements larger and sometimes easier to see on a syringe or dial on a pen.
Adding less diluent keeps injection volume smaller.
The useful middle ground is usually a concentration that:
- Fits comfortably within the vial or cartridge.
- Produces convenient syringe or pen measurements.
- Avoids unnecessarily tiny measurement volumes.
- Does not require an unnecessarily large injection volume.
- And remains within the stability and solubility requirements of the peptide.
For a real-world example, a 30 mg vial reconstituted with 3 mL of diluent gives us a very neat and tidy 1 mg/0.1mL. On the other hand, when working with a 40 mg vial, it might be beneficial to use just 2 mL of diluent to reach a 2 mg/0.1mL concentration, meaning that you only need 0.05mL to reach the desired 1 mg. This also is handy when you need larger doses in mg, but do not want to split across several syringes.
The goal is not "maximum concentration", the goal is a concentration that is easy to measure, chemically appropriate, and practical to use.
CHECK YOUR MATH TWICE
Before preparing anything, write down three numbers:
- How much peptide is in the vial.
- How much diluent you are adding.
- What concentration that creates.
Then calculate how much peptide is present in the volume you intend to measure. This is particularly important when switching between different vial strengths or changing the amount of diluent used.
A pen or syringe will faithfully deliver whatever volume you tell it to. It has no idea whether the concentration inside is the one you intended.
INSULIN SYRINGES
Insulin syringes are the simplest option for withdrawing small amounts from a vial.
Advantages:
- They are inexpensive.
- They are sterile and disposable.
- You draw directly from the vial.
- You can visually confirm the volume.
_ There are no cartridges or additional moving parts.
The main thing to remember is that the "units" printed on an insulin syringe describe volume according to that syringe's scale. They do not directly tell you how many milligrams of peptide you are measuring, that depends entirely on the concentration of the solution.
Use a new sterile syringe and needle every time, never reuse a syringe to enter a vial.
PEPTIDE PENS
Reusable peptide pens can make repeated use more convenient. A prepared solution is placed into a compatible cartridge or reservoir, and the pen advances the plunger in measured increments.
Advantages include:
- Compact size.
- Convenient repeat use.
- Very small replaceable pen needles.
- Consistent mechanical dispensing once correctly configured.
The tradeoff is added complexity.
You need to understand:
- The cartridge volume.
- The concentration of the solution.
- The pen's graduation or click system.
- How much liquid each increment actually delivers.
A pen does not remove the need to calculate concentration correctly. If the solution inside the cartridge is prepared incorrectly, the pen will simply dispense that incorrect concentration very consistently.
USE A FRESH NEEDLE EVERY TIME
Whether you use an insulin syringe or a peptide pen, use a new sterile needle for every injection.
Do not leave a pen needle attached between uses. Leaving the needle attached can allow leakage, air exchange, and contamination. Remove it after use and dispose of it in an appropriate sharps container. Lastly, never share a pen between people, even if the needle is changed.
STORING A FILLED PEPTIDE PEN
Putting a peptide into a pen does not change the peptide's storage requirements. If the reconstituted solution requires refrigeration, the filled cartridge or pen should remain refrigerated within the temperature limits of the device. Do not freeze a filled pen simply because the original dry peptide was stored frozen.
THE SHORT VERSION
For most people, the practical storage and handling rules are:
- Keep unreconstituted peptides cold, dry, and protected from light unless the product specifically requires another storage condition.
- Do not freeze products that specifically say "Do not freeze."
- Let frozen sealed vials warm before opening them.
- Refrigerate most working peptide solutions after reconstitution unless instructed otherwise.
- Avoid repeated freeze-thaw cycles.
- Use bacteriostatic water for compatible multi-dose preparations.
- Use sterile water when specifically required or for single-use preparation.
- Use a new sterile needle and syringe every time.
- Reconstitute gently rather than shaking aggressively.
- Insulin syringes are simple and direct.
- Peptide pens are more convenient but require correct cartridge and concentration setup.
- And always check the instructions for the actual peptide and formulation in front of you.


